Financhill
Back

Biogen 10K Form

Sell
40

BIIB
Biogen

Last Price:
$137.09
Seasonality Move:
-2.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIIB News And Ratings

See the #1 stock for the next 7 days that we like better than BIIB

BIIB Financial Statistics

Sales & Book Value

Annual Sales: $9.7B
Cash Flow: $694.6M
Price / Cash Flow: 7.93
Annual Sales: $114.71
Price / Book: 1.2

Profitability

EPS (TTM): 11.19000
Net Income (TTM): $1.6B
Gross Margin: $7.4B
Return on Equity: 10.33%
Return on Assets: 5.98%

Biogen Earnings Forecast

Key Biogen Financial Ratios

  • The Gross Profit Margin over the past 41 years for BIIB is 76.12%.
  • The Selling, General & Administrative Expenses for BIIB have been equal to 24.84% of Gross Profit Margin.
  • The Research & Development expenses have been 21.10% of Revenue.
  • The Interest Expense is 15.34% of Operating Income.
  • The Net Earning history of BIIB is 16.87% of Total Revenues.
  • Per Share Earnings over the last 41 years have been positive in 30 years.

Biogen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIIB
CUSIP: 09062X
Website: biogen.com

Debt

Debt-to-Equity Ratio: 0.38
Current Ratio: 1.35
Quick Ratio: 0.77

Price-to-Earnings

Trailing P/E Ratio: 12.23
Forward P/E Ratio: 8.63

BIIB Technical Analysis vs Fundamental Analysis

Sell
40
Biogen (BIIB) is a Sell

Is Biogen a Buy or a Sell?

  • Biogen stock is rated a Sell
    The current Biogen [BIIB] share price is $136.68. The Score for BIIB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.